Companies Have Discretion Over Whether to Disclose Coronavirus Infections

David Martin is quoted in The Wall Street Journal regarding companies’ decisions to disclose potential COVID-19 infections of executives. Mr. Martin says that while companies have leeway on executive medical disclosures, they often have a strong incentive to provide timely information. Doing so prevents employees from leaking information and investors from raising questions about why a CEO is no longer appearing in public. According to Mr. Martin, “There’s a practical issue: Does the company feel like it has to communicate with employees?”